• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Afro-Egyptian Journal of Infectious and Endemic Diseases
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 15 (2025)
Volume Volume 14 (2024)
Volume Volume 13 (2023)
Volume Volume 12 (2022)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 11 (2021)
Volume Volume 10 (2020)
Volume Volume 9 (2019)
Volume Volume 8 (2018)
Volume Volume 7 (2017)
Volume Volume 6 (2016)
Volume Volume 5 (2015)
Volume Volume 4 (2014)
Volume Volume 3 (2013)
Volume Volume 2 (2012)
Volume Volume 1 (2011)
Emara, M. (2022). Inhaled Steroids for Misdiagnosed Asthma Increase the ‎Frequency of Esophageal Moniliasis in Patients with ‎Achalasia. Afro-Egyptian Journal of Infectious and Endemic Diseases, 12(3), 298-299. doi: 10.21608/aeji.2022.259882
Mohamed H Emara. "Inhaled Steroids for Misdiagnosed Asthma Increase the ‎Frequency of Esophageal Moniliasis in Patients with ‎Achalasia". Afro-Egyptian Journal of Infectious and Endemic Diseases, 12, 3, 2022, 298-299. doi: 10.21608/aeji.2022.259882
Emara, M. (2022). 'Inhaled Steroids for Misdiagnosed Asthma Increase the ‎Frequency of Esophageal Moniliasis in Patients with ‎Achalasia', Afro-Egyptian Journal of Infectious and Endemic Diseases, 12(3), pp. 298-299. doi: 10.21608/aeji.2022.259882
Emara, M. Inhaled Steroids for Misdiagnosed Asthma Increase the ‎Frequency of Esophageal Moniliasis in Patients with ‎Achalasia. Afro-Egyptian Journal of Infectious and Endemic Diseases, 2022; 12(3): 298-299. doi: 10.21608/aeji.2022.259882

Inhaled Steroids for Misdiagnosed Asthma Increase the ‎Frequency of Esophageal Moniliasis in Patients with ‎Achalasia

Article 14, Volume 12, Issue 3, September 2022, Page 298-299  XML PDF (136.61 K)
Document Type: Case report
DOI: 10.21608/aeji.2022.259882
View on SCiNiTO View on SCiNiTO
Author
Mohamed H Emara email orcid
Hepatology, Gastroenterology and Infectious Diseases Department ,Faculty of Medicine , Kafrelshiekh University , KAFR ELSHIEKH ,Egypt
Abstract
A55-yearold patient with dysphagia had years of aspirations and was given ‎inhaled steroids for misdiagnosed  asthma and upon endoscopic examination ‎besides manifestations of achalasia found to have sever oesophageal moniliasis‎.
Main Subjects
Gastroenterology
Supplementary Files
download figure 1-1.jpg
Full Text

INTRODUCTION

Candida Albicans (esophageal moniliasis) is the most common cause of infectious ‎esophagitis so far. However, this kind of infectious esophagitis is linked to ‎immunocompromized conditions e.g. uncontrolled diabetes, HIV infection, ‎patients with advanced malignancy, and with prolonged heavy steroids use. ‎Furthermore, infrequently patients with achalasia and other obstructive lesions of ‎the esophagus with prolonged food stasis have been diagnosed with this infection ‎‎[1,2]. The case presented her is educational from different points. First, the ‎clinical inertia. This patient had years of complaints and per the current practice ‎guidelines [3] he should have been investigated by either imaging studies or ‎endoscopy years back for both the persistent pain and the progressive dysphagia ‎particularly with failure of empirical PPI therapy and persistence of complains. ‎Second, the misdiagnosis of asthma. In patients with achalasia, like our patient, ‎with stagnation of the food residues, recurrent aspirations with cough and ‎sometimes wheezes are occasionally misdiagnosed as asthma. This further ‎complicated the case because the inhaled steroids [4], as those given to our case, ‎are well known risk factors for the local fungal infection and this explains the ‎extensive affection seen in this patient. The extensive candidiasis shown in Figure ‎‎1 B should draw attention of clinicians to the odynophagic effect of this infection ‎among this category of patients

Case Presentation

A 55-year old male patient with hypertension on amlodipine had 4-5 years ‎history of central chest discomfort, dysphagia, with cough and was misdiagnosed ‎as GERD and asthma and given multiple courses of proton pump inhibitors ‎‎(PPIs) and due to cough was diagnosed as asthma and kept on inhaled steroid ‎‎(budesonide) in combination with a long-acting bronchodilator (formoterol ‎fumarate dihydrate). The patient when evaluated in our clinic 2-months ago did ‎not fulfill the diagnostic criteria of GERD and with the presence of the alaram ‎manifestation  dysphagia  a ‎decision for upper endoscopy was taken and it revealed ‎markedly dilated esophagus, tight lower esophageal sphincter and diffuse ‎esophageal moniliasis (Figure 1 A) that was confirmed in the films done for the ‎brushes and on histopathology specimens taken to rule out pseudoachalasia. The ‎patient was then examined by barium swallow that showed dilated esophagus ‎with smooth tapering lower end (Figure 1 B). The patient was treated for ‎esophageal moniliasis with oral antifungals for 2 weeks, followed by pneumatic ‎dilation by 30 mm balloon, and the inhaled steroids were discontinued‎.

DECLARATION

i. Funding: None‎

ii. Conflicts of interest/Competing interests: None ‎

iii. Ethics approval: Approved. ‎

iv.Consent to participate: written informed consent taken from the patient ‎

v. Consent for publication: written informed consent taken from the patient‎

vi. Availability of data and material: Available on request‎

vii. Code availability: Not applicable

viii. Authors' contributions: ME diagnosed the case, performed endoscopy, wrote the article an ‎approved it

References
1. Kumar P, Mohan S, Verma A, Baijal SS. Candida esophagitis in achalasia ‎cardia: Case report and review of literature. Saudi J Gastroenterol ‎‎2007; 13:88-90.‎

2.Wibowo AP, Perdana RF, Herawati S. Case report: Management of ‎achalasia with esophageal candidiasis and bradycardia at tertiary hospital. ‎Eurasia J Biosci 2000; 14: 6931-6937.‎

3.Hoversten P, Otaki F, Katzka DA. Course of Esophageal Candidiasis and ‎Outcomes of Patients at a Single Center. Clin Gastroenterol Hepatol. 2019 ‎Jan; 17(1):200-202.e1. doi: 10.1016/j.cgh.2018.04.035. Epub 2018 Apr ‎‎24. PMID: 29702297.‎

4. Oude Nijhuis RAB, Zaninotto G, Roman S, Boeckxstaens GE, Fockens P, ‎Langendam MW, Plumb AA, Smout A, Targarona EM, Trukhmanov AS, ‎Weusten B, Bredenoord AJ. European guidelines on achalasia: United ‎European Gastroenterology and European Society of ‎Neurogastroenterology and Motility recommendations. United European ‎Gastroenterol J. 2020 Feb; 8(1):13-33. doi: 10.1177/2050640620903213. ‎PMID: 32213062; PMCID: PMC7005998‎‎

Statistics
Article View: 343
PDF Download: 370
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.